BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
90 hedge funds and large institutions have $156M invested in BioSpecifics Technologies Corp. in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 48 increasing their positions, 16 reducing their positions, and 9 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 16
17% more capital invested
Capital invested by funds: $134M → $156M (+$22.6M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
1% less funds holding
Funds holding: 91 → 90 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$4.35M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.14M |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$1.55M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$972K |
| 5 |
Renaissance Technologies
New York
|
+$813K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Abdiel Capital Advisors
New York
|
-$11.8M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.84M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.69M |
| 4 |
Millennium Management
New York
|
-$683K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$441K |
BSTC Hedge Fund Activity: Q2 2016 in Review
90 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2016, worth a combined $156M — up 17% from $134M a quarter earlier.
Fund positioning in BSTC was balanced in Q2 2016: 9 funds opened new positions, 9 closed out, 48 added to existing stakes and 16 trimmed.
The largest buyer was Eagle Asset Management, opening a new position worth an estimated $4.35M. The largest seller was Abdiel Capital Advisors, exiting entirely with an estimated $11.8M sold.
- 90 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2016, down from 91 in Q1 2016.
- Funds reported $156M of BioSpecifics Technologies Corp. stock for Q2 2016, up 17% quarter-over-quarter.
- 9 funds opened new BioSpecifics Technologies Corp. positions in Q2 2016 and 9 closed out, a net change of 0 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q2 2016 was Eagle Asset Management, an estimated $4.35M added.
- The largest BioSpecifics Technologies Corp. seller in Q2 2016 was Abdiel Capital Advisors, an estimated $11.8M sold.
Based on aggregated 13F filings for Q2 2016.